论文部分内容阅读
由WHO主持的“原发性和继发性免疫缺陷病国际研讨会”每3年召开一次。会议除学术交流外,尚由指定的专家小组对原发性免疫缺陷病(PID)的命名、分类、诊断标准和规范治疗进行修改和审订。本届国际研讨会于1994年6月18～21日在意大利奥尔维托市召开,来自世界各地的200位知名学者作了专题报告和学术交流,内容涉及甚广,包括PID基础研究,流行病学调查、诊断和治疗新技术。我国代表在会上交流了黄芪的免疫调节效应和亚临床维生素A缺乏所致的免疫缺陷。本文简述与临床密切相关的部分内容。
The WHO International Symposium on Primary and Secondary Immunodeficiency Disorders is held every three years. In addition to academic exchanges, the meeting was also modified and finalized by the designated panel of experts on the nomenclature, classification, diagnostic criteria and standard treatment of primary immunodeficiency disease (PID). This international symposium was held in the city of Orvitalo, Italy from June 18 to June 21, 1994. 200 well-known scholars from around the world made special reports and academic exchanges covering a wide range of topics including PID basic research, Medical investigation, diagnosis and treatment of new technologies. My delegation exchanged the immunomodulatory effects of astragalus and the immunodeficiency caused by the lack of subclinical vitamin A at the meeting. This article outlines some of the most relevant aspects of clinical practice.